| Literature DB >> 25330344 |
Aram Heo1, Hyun-Jin Jang2, Jung-Suk Sung2, Woojun Park1.
Abstract
The effects of antibiotics on environment-originated nonpathogenic Acinetobacter species have been poorly explored. To understand the antibiotic-resistance mechanisms that function in nonpathogenic Acinetobacter species, we used an RNA-sequencing (RNA-seq) technique to perform global gene-expression profiling of soil-borne Acinetobacter oleivorans DR1 after exposing the bacteria to 4 classes of antibiotics (ampicillin, Amp; kanamycin, Km; tetracycline, Tc; norfloxacin, Nor). Interestingly, the well-known two global regulators, the soxR and the rpoE genes are present among 41 commonly upregulated genes under all 4 antibiotic-treatment conditions. We speculate that these common genes are essential for antibiotic resistance in DR1. Treatment with the 4 antibiotics produced diverse physiological and phenotypic changes. Km treatment induced the most dramatic phenotypic changes. Examination of mutation frequency and DNA-repair capability demonstrated the induction of the SOS response in Acinetobacter especially under Nor treatment. Based on the RNA-seq analysis, the glyoxylate-bypass genes of the citrate cycle were specifically upregulated under Amp treatment. We also identified newly recognized non-coding small RNAs of the DR1 strain, which were also confirmed by Northern blot analysis. These results reveal that treatment with antibiotics of distinct classes differentially affected the gene expression and physiology of DR1 cells. This study expands our understanding of the molecular mechanisms of antibiotic-stress response of environment-originated bacteria and provides a basis for future investigations.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25330344 PMCID: PMC4201530 DOI: 10.1371/journal.pone.0110215
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1A summary of genes upregulated and downregulated by distinct classes of antibiotics.
(A) The percentages of up- and down-regulated genes under treatment with 4 antibiotics. (B) Venn-diagram showing the number of overlapping genes upregulated by antibiotics of distinct classes. Fold-changes shown are a comparison of the RPKM values of exponentially growing control cells and of cells treated with each antibiotic. Upregulation of gene expression is >1.5-fold change in RPKM value, downregulation is <1.5-fold change.
Genes in A. oleivorans DR1 commonly upregulated by Amp, Km, Tc, and Nor.
| Locus_tag DR1 | Product | Genes | Fold-change | |||
| Amp | Km | Tc | Nor | |||
| AOLE_02445 | Enoyl-CoA hydratase |
| 4.62 | 1.78 | 2.34 | 1.87 |
| AOLE_04025 | Metal-dependent hydrolase | 3.84 | 2.97 | 4.43 | 2.45 | |
| AOLE_06735 | Putative short-chain dehydrogenase | 4.15 | 2.37 | 3.63 | 1.92 | |
| AOLE_06795 | Alkylhydroperoxidase | 2.94 | 2.23 | 2.92 | 1.58 | |
| AOLE_08565 | AraC-type DNA-binding domain-containing protein |
| 15.35 | 3.55 | 3.11 | 2.10 |
| AOLE_08595 | 3-Oxoadipate enol-lactonase |
| 3.08 | 1.78 | 2.73 | 1.57 |
| AOLE_08710 | 3-Oxoacyl-(acyl-carrier-protein) reductase |
| 4.18 | 4.13 | 3.10 | 2.09 |
| AOLE_08725 | NIPSNAP family protein | 3.35 | 3.55 | 6.22 | 2.09 | |
| AOLE_08765 | Shikimate dehydrogenase |
| 15.61 | 7.14 | 12.13 | 5.26 |
| AOLE_09075 | Transcriptional regulator |
| 5.71 | 4.27 | 2.03 | 1.68 |
| AOLE_09435 | DoxX family protein | 2.24 | 7.09 | 5.44 | 1.57 | |
| AOLE_09590 | Putative tonB-like protein |
| 1.57 | 3.90 | 3.42 | 1.67 |
| AOLE_10175 | Putative aliphatic sulfonate-binding protein |
| 2.69 | 2.04 | 5.02 | 1.65 |
| AOLE_11820 | Major facilitator superfamily transporter |
| 144.14 | 3.30 | 5.23 | 2.84 |
| AOLE_11830 | Methyltransferase domain-containing protein |
| 157.57 | 3.56 | 4.10 | 1.84 |
| AOLE_12115 | DMT-family permease | 3.07 | 2.36 | 3.88 | 2.44 | |
| AOLE_12135 | Redox-sensitive transcriptional activator SoxR |
| 2.52 | 4.00 | 2.53 | 2.88 |
| AOLE_12655 | ECF subfamily protein RNA polymerase sigma-24 subunit |
| 5.05 | 3.56 | 1.82 | 1.75 |
| AOLE_12705 | Glycine betaine ABC transporter substrate-binding protein |
| 1.71 | 1.77 | 1.75 | 2.49 |
| AOLE_12875 | Phenylacetic acid degradation protein |
| 17.54 | 3.56 | 4.68 | 2.10 |
| AOLE_13495 | Competence-damaged family protein |
| 5.05 | 13.36 | 7.42 | 2.63 |
| AOLE_14540 | Peptide deformylase |
| 2.87 | 4.45 | 1.85 | 2.75 |
| AOLE_14590 | 3-Phenylpropionate dioxygenase ferredoxin |
| 2.44 | 2.85 | 3.75 | 1.58 |
| AOLE_14800 | RNA polymerase sigma factor FecI |
| 27.98 | 17.79 | 1.87 | 2.94 |
| AOLE_16560 | Short-chain dehydrogenase | 1.71 | 2.44 | 2.24 | 1.57 | |
| AOLE_18975 | GNAT family acetyltransferase | 5.39 | 6.56 | 2.78 | 1.70 | |
Antimicrobial resistance-associated genes and target genes in A. oleivorans DR1.
| Locus_tag DR1 | Product | Description | Genes | Fold-change | |||
| Amp | Km | Tc | Nor | ||||
|
| |||||||
| AOLE_05220 | β-Lactamase | Class C β-lactamase |
| 1.05 | −2.06 | −3.45 | −1.31 |
| AOLE_06930 | β-Lactamase class C | Class C β-lactamase |
| 5.20 | 1.93 | 1.03 | 1.00 |
| AOLE_12585 | β-Lactamase | Class C β-lactamase |
| 1.41 | 1.19 | 1.72 | −1.09 |
| AOLE_17635 | β-Lactamase class C | Class C β-lactamase |
| 4.20 | 3.44 | 1.53 | 1.25 |
| AOLE_11070 | β-Lactamase class D | Class D β-lactamase |
| 1.28 | −2.14 | −1.43 | −1.65 |
| AOLE_00775 | Metallo-β-lactamase superfamily protein | Metallo-β-lactamase superfamily |
| −2.31 | 2.51 | 1.51 | −2.19 |
| AOLE_03925 | Putative metallo-β-lactamase | Metallo-β-lactamase superfamily |
| 3.17 | 2.56 | −2.55 | −1.06 |
| AOLE_10040 | β-Lactamase | Metallo-β-lactamase superfamily |
| −1.32 | 1.72 | −3.28 | −1.11 |
| AOLE_17515 | Metallo-β-lactamase superfamily protein | Metallo-β-lactamase superfamily |
| −1.17 | −1.05 | −1.33 | −1.05 |
| AOLE_01440 | Penicillin binding protein transpeptidase domain protein |
| −1.03 | −1.20 | −1.62 | −1.03 | |
| AOLE_01470 | Putative penicillin-binding protein (PonA) |
| −2.22 | −4.35 | −3.34 | −1.11 | |
| AOLE_05610 | Penicillin-binding protein 1B |
| −1.80 | −3.78 | −3.30 | −1.04 | |
| AOLE_14240 | Penicillin-binding protein 2 |
| −4.09 | −1.47 | −1.68 | −1.16 | |
|
| |||||||
| AOLE_08490 | Predicted aminoglycoside phosphotransferase | aminoglycoside 6′-acetyltransferase |
| 3.93 | 1.30 | −1.65 | −1.07 |
| AOLE_18475 | Aminoglycoside2'-N-acetyltransferase(AAC(2′)-Ib) | aminoglycoside 2′-acetyltransferase |
| −8.13 | 2.15 | 1.99 | −1.03 |
|
| |||||||
| AOLE_00020 | DNA gyrase subunit B | GyrB mutation |
| −1.82 | −1.65 | −1.48 | 1.24 |
| AOLE_00595 | DNA topoisomerase IV subunit B | GyrB mutation |
| −1.18 | 1.61 | −1.62 | 2.80 |
| AOLE_04195 | DNA gyrase subunit A | His-78→Asn |
| −2.17 | −1.51 | −3.26 | −1.01 |
| AOLE_18380 | DNA topoisomerase IV subunit A | GyrA mutation |
| −1.22 | −1.56 | −2.00 | 2.92 |
|
| |||||||
| AOLE_00955 | MFS transporter, metabolite:H+ symporter (MHS) family protein | MFS-family efflux pump |
| −3.37 | 1.97 | 1.31 | 1.00 |
| AOLE_00175 | MFS-family transporter | MFS-family efflux pump |
| −1.63 | 4.02 | 2.99 | 1.38 |
| AOLE_01040 | MFS-family transporter | MFS-family efflux pump |
| −4.27 | −3.45 | 1.14 | −1.32 |
| AOLE_12350 | MFS-family transporter | MFS-family efflux pump |
| −4.03 | −2.09 | 1.02 | 1.13 |
| AOLE_00050 | RND-type efflux pump | RND-family efflux pump |
| 9.53 | −1.03 | 1.52 | 1.02 |
| AOLE_04230 | Putative RND-family drug transporter | RND-family efflux pump |
| 2.16 | −15.53 | −2.57 | −1.21 |
| AOLE_09410 | RND-type efflux pump | RND-family efflux pump | 6.59 | 1.19 | 3.25 | 1.58 | |
| AOLE_18750 | RND-superfamily exporter | RND-family efflux pump | 77.60 | 19.11 | 1.34 | −1.13 | |
| AOLE_00035 | ABC transporter ATP-binding protein | ABC-family efflux pump |
| −3.32 | −1.18 | −2.10 | 1.22 |
| AOLE_01345 | Putative ABC transporter ATP-binding protein | ABC-family efflux pump |
| −3.46 | 1.23 | −3.34 | 1.06 |
| AOLE_17260 | ABC transporter ATP-binding protein | ABC-family efflux pump |
| −3.46 | −2.54 | −3.51 | −1.01 |
| AOLE_00290 | Multidrug-resistance protein norM | MATE-family efflux pump |
| −3.58 | −1.34 | 1.92 | −1.03 |
| AOLE_00530 | Na+-driven multidrug efflux pump | MATE-family efflux pump |
| 2.40 | 1.14 | 1.73 | 1.16 |
| AOLE_05880 | MATE efflux family protein | MATE-family efflux pump |
| -2.29 | −1.69 | 2.25 | 1.28 |
| AOLE_17460 | Multidrug ABC transporter | MATE-family efflux pump |
| −3.07 | 1.57 | −1.22 | −1.20 |
| AOLE_05535 | Quaternary ammonium compound-resistance protein QacE | SMR-family efflux pump |
| −2.23 | 2.48 | 1.71 | 1.47 |
| AOLE_16200 | Quaternary ammonium compound-resistance protein SugE | SMR-family efflux pump |
| −1.59 | 4.62 | 1.97 | 1.15 |
Figure 2Influence of distinct classes of antibiotics on cell morphology, and membrane permeability in DR1.
(A) The average cell size was measured from 50 cells treated with antibiotics. (B) Membrane permeability was measured using ANS. The error bars indicate standard deviation from triplicate experiments.
Figure 3Measurement of oxidative stress induced by antibiotics.
Intracellular superoxide-anion generation was measured using DHR 123. Fluorescence intensity was determined using flow cytometry and is represented as a histogram. FITC-A indicates the intensity of green fluorescence and the number of cells exhibiting the corresponding fluorescence intensity (amount of ROS production). The fluorescence histograms are of the samples before and after antibiotic treatment; solid and dotted lines are untreated cells and antibiotic-treated cells, respectively. (A) Amp, (B) Km, (C) Tc, (D) Nor. A shift to stronger fluorescence indicates a greater generation of oxidative stress.
Figure 4Expression of citrate-cycle genes in A. oleivorans DR1 treated with distinct antibiotics.
Gene-expression changes are represented by a color gradient that is based on the fold-changes of gene expression in response to antibiotic treatments.
Expression change of functional gene clusters.
| Locus_tag DR1 | Product | Genes | Fold change | |||
| Amp | Km | Tc | Nor | |||
|
| ||||||
| AOLE_07085 | Nucleotidyltransferase/DNA polymerase |
| −2.67 | 1.48 | 2.34 | 1.57 |
| AOLE_07375 | Recombinase A |
| 2.05 | 3.04 | 1.02 | 5.17 |
| AOLE_07965 | DNA-directed DNA polymerase UmuC |
| −1.43 | −2.26 | 2.24 | 4.20 |
| AOLE_07970 | DNA polymerase V component | −1.43 | −1.69 | −1.10 | 5.41 | |
| AOLE_11745 | SOS-response transcriptional repressor (RecA-mediated autopeptidases) |
| −1.18 | 1.82 | −1.57 | 3.15 |
| AOLE_14875 | DNA polymerase V component | 1.18 | 3.20 | 2.18 | 6.51 | |
| AOLE_14880 | DNA-directed DNA polymerase UmuC |
| −4.42 | −2.49 | 1.51 | 2.13 |
| AOLE_18420 | DNA polymerase IV |
| −1.67 | 1.34 | −1.01 | −1.53 |
|
| ||||||
| AOLE_05830 | Putative DNA-binding/iron metalloprotein/AP endonuclease | −8.18 | 2.00 | −1.26 | −1.33 | |
| AOLE_13505 | Metalloendopeptidase-like membrane protein |
| 2.96 | 1.35 | −2.53 | 1.06 |
| AOLE_14215 | Endonuclease III |
| −3.09 | 1.81 | −1.31 | −1.19 |
| AOLE_14840 | HNH endonuclease | −1.04 | 5.00 | −1.12 | −1.43 | |
| AOLE_18425 | Endoribonuclease L−PSP family protein |
| −1.31 | −1.42 | −7.04 | 1.11 |
| AOLE_18840 | Endoribonuclease L-PSP family protein |
| 5.89 | −2.73 | 1.24 | −1.16 |
| AOLE_03065 | Formamidopyrimidine-DNA glycosylase |
| −2.32 | 1.72 | −1.24 | −1.03 |
| AOLE_10805 | Uracil-DNA glycosylase |
| −2.90 | 1.89 | −1.41 | −1.02 |
|
| ||||||
| AOLE_01750 | Cu/Zn superoxide dismutase |
| 2.99 | −1.24 | 1.10 | −1.07 |
| AOLE_02915 | Peroxiredoxin |
| 2.72 | −1.38 | −3.47 | −1.98 |
| AOLE_05305 | Superoxide dismutase |
| −1.57 | −1.27 | −1.54 | −1.16 |
| AOLE_07635 | Thioredoxin |
| −1.77 | 5.36 | 8.61 | 2.10 |
| AOLE_11770 | Catalase |
| 3.98 | 1.22 | 1.56 | −1.17 |
| AOLE_12135 | Redox-sensitive transcriptional activator SoxR |
| 2.52 | 4.00 | 2.53 | 2.88 |
| AOLE_12755 | Catalase |
| 1.41 | 1.54 | 2.09 | −1.75 |
| AOLE_13380 | Peroxiredoxin |
| 1.23 | 1.24 | −1.87 | −1.23 |
| AOLE_14380 | Hydrogen peroxide-inducible genes activator |
| 1.11 | 1.40 | −1.79 | 1.08 |
| AOLE_16430 | Thioredoxin |
| 1.09 | −1.24 | −2.07 | −1.09 |
| AOLE_17390 | Catalase |
| −1.19 | −3.11 | −2.88 | 1.34 |
| AOLE_18445 | SoxR-family transcriptional regulator |
| 1.17 | 1.38 | 1.47 | −1.32 |
Figure 5SOS-response induction in Acinetobacter oleivorans DR1.
The mutation frequency, which corresponds to the rifampicin-resistance CFU count divided by the total CFU count, was measured and is represented on the Y-axis in the case of each antibiotic. (A) MMC-induced mutagenesis frequency. (B) Mutagenesis frequency induced by antibiotics of distinct classes. (C) Effect of antibiotics on recA expression was confirmed using a GFP fusion protein.
Figure 6Verification of endonuclease IV activity by using the base-excision DNA-repair assay.
DNA-repair capability of endonuclease IV was measured in DR1 exposed to distinct classes antibiotics. (A) Schematic representation of DNA substrate containing a site-specific THF residue. (B) A representative autoradiograph of gel electrophoresis to measure in vitro BER products. (C) Quantification of endonuclease IV BER activity. S, substrate; P, product; C, positive control; U, untreated negative control. Error bars indicate the S.D. calculated for each data point (n = 2).